Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Prospective Study of the Safety and Efficacy of the HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids

NCT01841970 is registered in ClinicalTrials.gov with Medtronic - MITG as lead sponsor.

NCT NCT01841970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01841970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Prospective Study of the Safety and Efficacy of the HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids
Lead sponsor
Medtronic - MITG
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
January 31, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoids, internal